SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease

Loïs A K van der Pluijm1, Angela Koudijs1, Wendy Stam1

  • 1Department of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, the Netherlands.

PubMed
Abstract

Insights

Sodium glucose co-transporter-2 (SGLT2) inhibitors promote kidney cell repopulation by juxtaglomerular cells of renin lineage (CoRL). This effect is selective, depending on the type of kidney injury, and may explain SGLT2 inhibitors' renoprotective benefits.

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Sodium glucose co-transporter-2 (SGLT2) inhibitors are known for renal protective effects in chronic kidney disease (CKD) and acute kidney injury (AKI).
  • The precise mechanism underlying these renoprotective effects remains incompletely understood.
  • Juxtaglomerular cells of renin lineage (CoRL) are identified as progenitor cells for various glomerular cell types in kidney disease.

Purpose of the Study:

  • To investigate the impact of SGLT2 inhibition on glomerular cell repopulation by CoRL.
  • To examine the phenotypic commitment of CoRL-derived cells under SGLT2 inhibition in different kidney injury models.

Main Methods:

  • Experiments utilized Ren1cre-tdTomato lineage-trace mice subjected to 5/6 nephrectomy (5/6NX) for CKD or bilateral ischemia reperfusion injury (bIRI) for AKI.
  • Mice received daily oral administration of the SGLT2 inhibitor empagliflozin (10 mg/kg) for 14 days.
  • Changes in glomerular cell populations and kidney function were assessed.

Main Results:

  • Both 5/6NX and bIRI increased glomerular CoRL-derived cells. SGLT2 inhibition improved kidney function and reduced glomerulosclerosis in 5/6NX models but not in bIRI models.
  • Empagliflozin increased the number of CoRL-derived glomerular cells in both injury models.
  • SGLT2 inhibition promoted CoRL-derived podocytes in 5/6NX and increased parietal epithelial and mesangial cells in bIRI models.

Conclusions:

  • SGLT2 inhibition via empagliflozin enhances CoRL-mediated glomerular repopulation.
  • The specific cell types repopulated by CoRL are dependent on the nature of the experimental kidney injury.
  • These findings suggest a novel mechanism for the renoprotective action of SGLT2 inhibitors involving selective glomerular cell regeneration.

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.2K
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.7K
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
271